Latest Regulatory Approval News

Santana Minerals has announced a delay in submitting its Fast Track Approvals Application due to pending ecological consultant reports, missing the previously set June 30 deadline. The company remains optimistic about finalising the reports soon and prioritising the submission.

Tivan Limited has made significant progress on a revised access road for its Speewah Fluorite Project, balancing infrastructure needs with cultural heritage preservation. The company also secured key native title agreements and regulatory approvals supporting its feasibility study and joint venture with Sumitomo Corporation.

Vulcan Energy has received building permits for its 30MW geothermal renewable energy plant in Germany, advancing its goal of carbon-neutral lithium production for Europe’s battery industry.

The Reject Shop has announced a fully franked special dividend of $0.77 per share as part of its acquisition by Dollarama, boosting the total transaction consideration to $6.68 per share.

ASPI Isotopes Inc. has proposed a scheme to acquire all Renergen shares at a 41.3% premium, aiming to create a global critical materials powerhouse. The deal, subject to shareholder and regulatory approval, will delist Renergen from multiple exchanges.

Renergen Limited shareholders have received a detailed circular outlining ASP Isotopes Inc.'s firm intention to acquire the company through a scheme of arrangement, with a general meeting scheduled for 10 July 2025 to approve the deal.

NexGen Energy has secured regulatory approval for a significant infrastructure upgrade at its Rook I uranium project, setting the stage for expanded exploration and operational efficiency in 2025.

FireFly Metals Ltd has announced a flow-through share offer aiming to raise approximately A$11.2 million, targeting Canadian investors to fund regional exploration drilling. This offer complements a broader capital raising strategy to advance development at the Ming Mine and other key projects.

Cleo Diagnostics unveils a pioneering blood test for early ovarian cancer detection, boasting superior accuracy to existing methods and targeting a significant U.S. market opportunity.

Cochlear Limited has lowered its FY25 earnings guidance due to slower-than-expected sales growth and a sharper decline in Services revenue. Despite this, implant unit growth remains on track, driven by emerging markets.

Talga Group has cleared the last regulatory hurdle for its Nunasvaara South graphite mine in Sweden, paving the way for production of battery anode materials critical to the green transition.

EVE Health Group has launched a $1.5 million capital raise alongside the acquisition of biotech firm Nextract, aiming to expand its footprint in health and pharmaceutical products focused on erectile dysfunction and period pain.